DarioHealth Corp. (DRIO) Stock

DarioHealth Corp., headquartered in New York, New York, operates as a leading digital therapeutics company with a global presence spanning the United States, Canada, the European Union, Australia, and New Zealand. The company specializes in providing comprehensive metabolic health solutions under the Dario brand, addressing conditions such as diabetes, hypertension, and weight management. DarioHealth offers a range of innovative products and services including Dario Musculoskeletal solutions for preventing and treating common musculoskeletal conditions, as well as behavioral health solutions that optimize access to evidence-based care. Their chronic condition management solutions and proprietary DarioEngage care management platform empower users with personalized tools for effective self-care and remote monitoring.

In addition to its robust digital health offerings, DarioHealth provides a variety of medical devices and disposables, including smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, and biofeedback sensor devices. These products are integral to their diabetes management programs, which encompass lifestyle modifications, dietary guidance, advanced tracking capabilities, and personalized coaching. Formerly known as LabStyle Innovations Corp., the company rebranded as DarioHealth Corp. in July 2016 to better reflect its expanded focus on digital therapeutics and patient-centric healthcare innovations.

Established in 2011, DarioHealth has continually evolved its technology-driven approach to chronic disease management, leveraging cutting-edge digital tools to empower individuals in managing their health effectively. With a commitment to improving outcomes through accessible, user-friendly solutions, DarioHealth remains at the forefront of transforming how chronic conditions are monitored, managed, and treated globally.